Do Something – ACT against Afib

Do Something.

Surgical Ablation Guidelines are Advancing

Surgical-Ablation-Historical-Guidelines

Cox Maze IV yields the highest efficacy for Afib treatment, but literature shows progressive
efficacy for each additive lesion set of Cox Maze IV
Sources:

January, C. T., et al. (2019). 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for
the Management of Patients With Atrial Fibrillation: A Report of the American College of
Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart
Rhythm Society. Circulation, CIR-0000000000000665.
Badhwar, et al. (2017). The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the
Surgical Treatment of Atrial Fibrillation. Ann Thorac Surg, 103(1):329-41.
January, C.T., et al. (2014). 2014 AHA/ACC/HRS guideline for the management of patients with atrial
fibrillation: a report of the American College of Cardiology/American Heart Association Task Force
on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol, 64(21):e1-76.
*Calkins, H., et al. (2017). 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter
and surgical ablation of atrial fibrillation. Heart Rhythm, 14(10):e275-444. AVR/CABG concomitant
ablation Class I LOR for symptomatic persistent and long-standing persistent “refractory or
intolerant to at least one Class 1 or 3 antiarrhythmic medication.”
Meier, B., et al. (2014). EHRA/EAPCI expert consensus statement on catheter-based left atrial
appendage occlusion. Europace, 16(10):1397-416.
Cox, J.L., et al. (1991). Dr. Cox performed first surgical ablation using maze I; Successful
surgical treatment of atrial fibrillation. Review and clinical update. JAMA, 266 (14):1976-80. COR :
Class of Recommendation LOE : Level of Evidence

7 of 13
PM-US-0808A-0321-G